Rocket One Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Rocket One Inc. (RKTO) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$59.58 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2023-03-31
- Rocket One Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-12-31 was $1.04K.
- Rocket One Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-09-30 was -$29.14K.
- Rocket One Inc. foreign currency transaction gain (loss), unrealized for fiscal 2021 was -$59.58K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$28.09K derived: sum of 2 quarters · filed 2023-03-31 | -$59.58K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$29.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$60.63K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$31.49K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |